Bartoli-Abdou J - Search Results

1

Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis.

Speed V, Green B, Roberts LN, Woolcombe S, Bartoli-Abdou J, Barsam S, Byrne R, Gee E, Czuprynska J, Brown A, Duffy S, Vadher B, Patel R, Scott V, Gazes A, Patel RK, Arya R, Patel JP. Speed V, et al. Among authors: bartoli abdou j. J Thromb Haemost. 2020 Sep;18(9):2296-2307. doi: 10.1111/jth.14948. J Thromb Haemost. 2020. PMID: 32511863 Free article.

2

Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study.

Bartoli-Abdou JK, Patel JP, Crawshaw J, Vadher B, Brown A, Roberts LN, Patel RK, Arya R, Auyeung V. Bartoli-Abdou JK, et al. Thromb Res. 2018 Feb;162:62-68. doi: 10.1016/j.thromres.2017.12.021. Epub 2018 Jan 2. Thromb Res. 2018. PMID: 29306122 Free article.

3

Associations between illness beliefs, medication beliefs, anticoagulation-related quality of life, and INR control: Insights from the Switching Study.

Bartoli-Abdou JK, Patel JP, Xie R, Dzahini O, Vadher B, Brown A, Roberts LN, Patel RK, Arya R, Auyeung V. Bartoli-Abdou JK, et al. Res Pract Thromb Haemost. 2018 Jun 7;2(3):497-507. doi: 10.1002/rth2.12116. eCollection 2018 Jul. Res Pract Thromb Haemost. 2018. PMID: 30046754 Free PMC article.

4

Long-term adherence to direct acting oral anticoagulants and the influence of health beliefs after switching from vitamin-K antagonists: Findings from the Switching Study.

Bartoli-Abdou JK, Patel JP, Vadher B, Brown A, Roberts LN, Patel RK, Arya R, Auyeung V. Bartoli-Abdou JK, et al. Thromb Res. 2021 Dec;208:162-169. doi: 10.1016/j.thromres.2021.11.003. Epub 2021 Nov 15. Thromb Res. 2021. PMID: 34801919 Free article.

5

The transition from hospital to home following acute coronary syndrome: an exploratory qualitative study of patient perceptions and early experiences in two countries.

Crawshaw J, Bartoli-Abdou JK, Weinman J, McRobbie D, Stebbins M, Brock T, Auyeung V. Crawshaw J, et al. Among authors: bartoli abdou jk. Int J Pharm Pract. 2021 Feb 10;29(1):61-69. doi: 10.1093/ijpp/riaa009. Int J Pharm Pract. 2021. PMID: 33793821

6

Clinical outcomes of patients receiving long-term fondaparinux for thrombotic antiphospholipid syndrome.

Bor B, Doyle AJ, Bartoli-Abdou JK, Hackett A, Collings V, Omrani F, Foskett C, Wareing A, Young J, Breen KA, Hunt BJ. Bor B, et al. Among authors: bartoli abdou jk. Lupus. 2024 Nov;33(13):1446-1454. doi: 10.1177/09612033241285225. Epub 2024 Sep 16. Lupus. 2024. PMID: 39283750

7

Factor Xa Inhibitor Plasma Concentrations and Clinical Outcomes in Patients Weighing ≤50 kg-Experience from Four UK Centers.

Speed V, Clapham R, Bartoli-Abdou J, Stirling K, Akor F, Collings V, Patel R, Byrne R, Arya R, Patel JP. Speed V, et al. Among authors: bartoli abdou j. Thromb Haemost. 2024 Feb;124(2):177-180. doi: 10.1055/s-0043-1775982. Epub 2023 Oct 16. Thromb Haemost. 2024. PMID: 37846464 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters